EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.6.5.5 | Cataract |
1370456 |
Identification and characterization of the enzymatic activity of zeta-crystallin from guinea pig lens. A novel NADPH:quinone oxidoreductase. |
causal interaction unassigned |
3 0 |
1.6.5.5 | Cataract |
1390943 |
A guinea-pig hereditary cataract contains a splice-site deletion in a crystallin gene. |
unassigned |
0 |
1.6.5.5 | Lens Diseases |
1390943 |
A guinea-pig hereditary cataract contains a splice-site deletion in a crystallin gene. |
unassigned |
0 |
1.6.5.5 | Carcinoma, Hepatocellular |
1549602 |
Rapid detection of inducers of enzymes that protect against carcinogens. |
ongoing research unassigned |
3 0 |
1.6.5.5 | Cataract |
1623948 |
Mutant zeta-crystallin from guinea-pig hereditary cataracts has altered structural and enzymatic properties. |
unassigned |
0 |
1.6.5.5 | Cataract |
1695576 |
The transcripts of zeta-crystallin, a lens protein related to the alcohol dehydrogenase family, are altered in a guinea-pig hereditary cataract. |
unassigned |
0 |
1.6.5.5 | Neoplasms |
1739405 |
Enzymology of the reduction of the potent benzotriazine-di-N-oxide hypoxic cell cytotoxin SR 4233 (WIN 59075) by NAD(P)H: (quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from Walker 256 rat tumour cells. |
ongoing research unassigned |
2 0 |
1.6.5.5 | Carcinoma |
1901207 |
The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide) |
diagnostic usage ongoing research therapeutic application unassigned |
1 3 1 0 |
1.6.5.5 | Carcinogenesis |
2107967 |
Long term effects of benzo(a)pyrene on the activity of NAD(P)H:quinone reductase in the forestomach and glandular stomach of ICR/Ha mice. |
ongoing research unassigned |
2 0 |
1.6.5.5 | Cataract |
2318275 |
Association of hereditary cataracts in strain 13/N guinea-pigs with mutation of the gene for zeta-crystallin. |
causal interaction diagnostic usage therapeutic application unassigned |
4 3 1 0 |